<!DOCTYPE html>
<html lang="en"><head>
<script src="chronic-interstitial-lung-diseases_files/libs/clipboard/clipboard.min.js"></script>
<script src="chronic-interstitial-lung-diseases_files/libs/quarto-html/tabby.min.js"></script>
<script src="chronic-interstitial-lung-diseases_files/libs/quarto-html/popper.min.js"></script>
<script src="chronic-interstitial-lung-diseases_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="chronic-interstitial-lung-diseases_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="chronic-interstitial-lung-diseases_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="chronic-interstitial-lung-diseases_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="chronic-interstitial-lung-diseases_files/libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.340">

  <meta name="author" content="Serdar Balcı">
  <title>Title</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="chronic-interstitial-lung-diseases_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="chronic-interstitial-lung-diseases_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="chronic-interstitial-lung-diseases_files/libs/revealjs/dist/theme/quarto.css" id="theme">
  <link href="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-light">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Title</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Serdar Balcı 
</div>
</div>
</div>

</section>
<section class="slide level2">


<img data-src="img%5CChronic-Interstitial-Lung-Diseases0.jpg" class="r-stretch"></section>
<section id="chronic-interstitial-lung-diseases" class="title-slide slide level1 center">
<h1>Chronic Interstitial Lung Diseases</h1>

</section>

<section id="serdar-balci-md" class="title-slide slide level1 center">
<h1>Serdar BALCI, MD</h1>

</section>

<section id="chronic-interstitial-lung-diseases-1" class="title-slide slide level1 center">
<h1>Chronic Interstitial Lung Diseases</h1>
<p><strong>Chronic Interstitial (Restrictive, Infiltrative) Lung Diseases</strong></p>
<p><strong>Heterogeneous group of disorders</strong></p>
<p><strong>Bilateral, often patchy, usually chronic</strong></p>
<p><strong>Involvement of the pulmonary connective tissue</strong></p>
<p><strong>Most peripheral and delicate interstitium in the alveolar walls</strong></p>
<ul>
<li><strong>Reduced compliance</strong>
<ul>
<li><strong>More pressure is required to expand the lungs</strong></li>
<li><strong>They are stiff</strong></li>
</ul></li>
<li><strong>Increased effort of breathing (dyspnea)</strong></li>
<li><strong>Abnormalities in the ventilation–perfusion ratio → Hypoxia</strong></li>
<li><strong>Respiratory failure, pulmonary hypertension, cor pulmonale</strong></li>
<li><strong>Advanced forms</strong>
<ul>
<li><strong>Scarring and gross destruction of the lung</strong></li>
<li><strong>End-stage or “honeycomb” lung</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases1.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases2.png"></p>
</section>

<section id="fibrosing-diseases" class="title-slide slide level1 center">
<h1>FIBROSING DISEASES</h1>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases3.png" class="r-stretch"></section>

<section id="idiopathic-pulmonary-fibrosis" class="title-slide slide level1 center">
<h1>IDIOPATHIC PULMONARY FIBROSIS</h1>

</section>

<section id="idiopathic-pulmonary-fibrosis-1" class="title-slide slide level1 center">
<h1>Idiopathic Pulmonary Fibrosis</h1>
<ul>
<li><em>Cryptogenic fibrosing alveolitis</em></li>
<li><strong>Unknown etiology</strong></li>
<li><strong>Patchy, progressive, bilateral interstitial fibrosis</strong></li>
<li><strong>Males are affected more often than females</strong></li>
<li><strong>2/3 of patients &gt;60 years at presentation</strong></li>
<li><em>Usual interstitial pneumonia</em>
<ul>
<li><strong>Radiologic and histologic pattern of fibrosis</strong></li>
</ul></li>
<li><strong>Progressive disease</strong>
<ul>
<li><strong>Die in 3 yrs</strong></li>
<li><strong>Lung transplantation</strong></li>
</ul></li>
<li><strong>Caused by</strong>
<ul>
<li><strong>Repeated cycles of epithelial activation/injury</strong></li>
<li><strong>Some unidentified agent</strong></li>
</ul></li>
<li><strong>Histopathologic features</strong>
<ul>
<li><strong>Inflammation</strong></li>
<li><strong>TH2 response with eosinophils, mast cells, IL-4, and IL-13</strong></li>
<li><strong>Alternatively activated macrophages</strong></li>
<li><strong>Abnormal epithelial repair at the sites of damage and inflammation</strong></li>
<li><strong>Exuberant fibroblastic or myofibroblastic proliferation</strong></li>
<li><strong>Fibroblastic foci</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases4.png"></p>
<p><strong>from injured type I pneumocytes</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases5.png"></p>
<ul>
<li><strong>Retraction of scars along the interlobular septa → cobblestones</strong></li>
<li><strong>Fibrosis</strong>
<ul>
<li><strong>Lower lobe predominance</strong></li>
<li><strong>Subpleural regions and along the interlobular septa</strong></li>
</ul></li>
<li><strong>Usual interstitial pneumonia</strong>
<ul>
<li><strong>Patchy interstitial fibrosis</strong></li>
<li><strong>Varies in intensity</strong></li>
</ul></li>
</ul>
<p><strong>Early stages</strong></p>
<p><strong>Alternating areas of light-colored fibrosis and normal lung</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases6.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><strong>the degree of fibrosis increases and small subpleural cysts appear</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases7.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><strong>visceral pleural surface becomes progressively more irregular</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases8.png"></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases9.png"></p>
<p><strong>Late stage progressive cyst formation Honeycomb lung</strong></p>
<p><strong>Autopsy Pathology: A Manual and Atlas</strong></p>
<p><strong>Usual interstitial pneumonia. The fibrosis is more pronounced in the subpleural region. </strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases10.png"></p>
<p><strong>Usual interstitial pneumonia. Fibrosis in the subpleural region.</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases11.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Fibroblastic focus with fibers running parallel to surface and bluish myxoid extracellular matrix. Honeycombing is present to the left.</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases12.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><p><strong>Early lesions</strong></p>
<ul>
<li><strong>Exuberant fibroblastic proliferation</strong></li>
<li><strong>Fibroblastic foci</strong></li>
</ul></li>
<li><p><strong>Over time</strong></p>
<ul>
<li><strong>More collagenous</strong></li>
<li><strong>Less cellular</strong></li>
</ul></li>
<li><p><strong>Existence of both early and late lesions → temporal heterogeneity</strong></p></li>
<li><p><strong>Dense fibrosis → collapse of alveolar walls → formation of cystic spaces</strong></p>
<ul>
<li><strong>Honeycomb fibrosis</strong></li>
</ul></li>
<li><p><strong>Interstitial inflammation</strong></p>
<ul>
<li><strong>Patchy</strong></li>
<li><strong>Lymphocytes and occasional plasma cells, mast cells, and eosinophils</strong></li>
</ul></li>
<li><p><strong>Secondary pulmonary hypertensive changes</strong></p>
<ul>
<li><strong>Intimal fibrosis, medial thickening of pulmonary arteries</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases13.png"></p>
</section>

<section id="nonspecific-interstitial-pneumonia" class="title-slide slide level1 center">
<h1>NONSPECIFIC INTERSTITIAL PNEUMONIA</h1>

</section>

<section id="nonspecific-interstitial-pneumonia-1" class="title-slide slide level1 center">
<h1>Nonspecific Interstitial Pneumonia</h1>
<p><strong>Chronic bilateral interstitial lung disease</strong></p>
<p><strong>Unknown etiology</strong></p>
<p><strong>Distinct clinical, radiologic, and histologic features</strong></p>
<p><strong>Much better prognosis than that for IPF</strong></p>
<ul>
<li><strong>Histologic appearance</strong></li>
<li><strong>Cellular pattern</strong>
<ul>
<li><strong>Mild-to-moderate chronic interstitial inflammation</strong></li>
<li><strong>A uniform or patchy distribution</strong></li>
<li><strong>Better outcome than those with the fibrosing pattern and UIP</strong></li>
</ul></li>
<li><strong>Fibrosing pattern</strong>
<ul>
<li><strong>Diffuse or patchy interstitial fibrosis</strong></li>
<li><strong>Without the temporal heterogeneity</strong></li>
</ul></li>
<li><strong>Fibroblastic foci and honeycombing --&gt; in both variants</strong></li>
</ul>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases14.png" class="r-stretch"></section>

<section id="cryptogenic-organizing-pneumonia" class="title-slide slide level1 center">
<h1>CRYPTOGENIC ORGANIZING PNEUMONIA</h1>

</section>

<section id="cryptogenic-organizing-pneumonia-1" class="title-slide slide level1 center">
<h1>Cryptogenic Organizing Pneumonia</h1>
<p><strong>Bronchiolitis obliterans organizing pneumonia (BOOP)</strong></p>
<p><strong>Unknown etiology</strong></p>
<p><strong>Cough and dyspnea</strong></p>
<p><strong>Subpleural or peribronchial patchy areas of air space consolidation</strong></p>
<ul>
<li><strong>Histologic examination</strong>
<ul>
<li><strong>Polypoid plugs of loose organizing connective tissue within alveolar ducts, alveoli, and often bronchioles</strong></li>
<li><strong>Connective tissue is all of the same age</strong></li>
<li><strong>Underlying lung architecture is normal</strong></li>
</ul></li>
</ul>
<p><strong>Cryptogenic organizing pneumonia</strong></p>
<p><strong>Alveolar spaces are filled with balls of fibroblasts (Masson bodies)</strong></p>
<p><strong>Adjacent alveoli are relatively normal, compressed</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases15.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases16.png"></p>
</section>

<section id="pulmonary-involvement-in-collagen-vascular-diseases" class="title-slide slide level1 center">
<h1>PULMONARY INVOLVEMENT IN COLLAGEN VASCULAR DISEASES</h1>

</section>

<section id="pulmonary-involvement-in-collagen-vascular-diseases-1" class="title-slide slide level1 center">
<h1>Pulmonary Involvement inCollagen Vascular Diseases</h1>
<ul>
<li><strong>Systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, dermatomyositis-polymyositis</strong></li>
<li><strong>Several histologic variants can be seen</strong>
<ul>
<li><strong>NSIP, UIP pattern, vascular sclerosis, organizing pneumonia, bronchiolitis</strong></li>
</ul></li>
<li><strong>Pleural involvement</strong>
<ul>
<li><strong>Pleuritis, pleural nodules, and pleural effusion</strong></li>
</ul></li>
</ul>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases17.png" class="r-stretch"></section>

<section id="pneumoconioses" class="title-slide slide level1 center">
<h1>PNEUMOCONIOSES</h1>

</section>

<section id="pneumoconioses-1" class="title-slide slide level1 center">
<h1>Pneumoconioses</h1>
<ul>
<li><strong>Non-neoplastic lung reaction to inhalation of mineral dusts</strong>
<ul>
<li><strong>coal dust, silica, asbestos</strong></li>
</ul></li>
<li><strong>Diseases induced by organic as well as inorganic particulates</strong></li>
<li><strong>Chemical fume- and vapor-induced non-neoplastic lung diseases</strong></li>
</ul>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases18.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Size, shape, solubility, and reactivity of the particles</strong>
<ul>
<li><strong>&gt;5-10 µm are unlikely to reach distal airways</strong></li>
<li><strong>&lt;0.5 µm move into and out of alveoli, often without substantial deposition and injury</strong></li>
<li><strong>1-5 µm in diameter are the most dangerous</strong>
<ul>
<li><strong>Get lodged at the bifurcation of the distal airways</strong></li>
</ul></li>
</ul></li>
<li><strong>Coal dust</strong>
<ul>
<li><strong>Relatively inert</strong></li>
<li><strong>Large amounts required for clinically detectable disease</strong></li>
</ul></li>
<li><strong>Silica, asbestos, and beryllium</strong>
<ul>
<li><strong>More reactive than coal dust</strong></li>
<li><strong>Fibrotic reactions at lower concentrations</strong></li>
</ul></li>
<li><strong>Dust is entrapped in the mucus blanket</strong>
<ul>
<li><strong>Rapidly removed by ciliary movement</strong></li>
</ul></li>
<li><strong>Particles become impacted at alveolar duct bifurcations</strong>
<ul>
<li><strong>Macrophages accumulate and engulf the trapped particulates</strong></li>
<li><strong>Particles activate the inflammasome and induce IL-1 production</strong></li>
</ul></li>
<li><strong>Inflammatory response, fibroblast proliferation, collagen deposition</strong></li>
<li><strong>When particles enter lymphatics → amplification and extension of the local reaction</strong></li>
<li><strong>Tobacco smoking worsens the effects of all inhaled dusts</strong>
<ul>
<li><strong>espescially with asbestos</strong></li>
</ul></li>
</ul>
</section>

<section id="coal-workers-pneumoconiosis" class="title-slide slide level1 center">
<h1>Coal Worker’s Pneumoconiosis</h1>
<ul>
<li><strong>Pulmonary anthracosis</strong>
<ul>
<li><strong>Most innocuous coal-induced pulmonary lesion in coal miners</strong></li>
<li><strong>Commonly seen in all urban dwellers and tobacco smokers</strong></li>
<li><strong>Carbon pigment engulfed by alveolar or interstitial macrophages</strong></li>
<li><strong>Accumulate in the connective tissue along the lymphatics</strong></li>
<li><strong>Including the pleural lymphatics, in lymph nodes</strong></li>
</ul></li>
<li><strong>Simple CWP</strong>
<ul>
<li><strong>Coal macules</strong></li>
<li><strong>Larger coal nodule</strong></li>
</ul></li>
<li><strong>Coal macule</strong>
<ul>
<li><strong>Dust-laden macrophages</strong></li>
<li><strong>Small amounts of collagen fibers arrayed in a delicate network</strong></li>
<li><strong>Upper lobes and upper zones of the lower lobes</strong></li>
<li><strong>Centrilobular emphysema can occur</strong></li>
</ul></li>
<li><strong>Complicated CWP</strong>
<ul>
<li><strong>Progressive Massive Fibrosis on a background of simple CWP</strong></li>
<li><strong>Coalescence of coal nodules</strong></li>
<li><strong>Years to develop</strong></li>
<li><strong>Multiple, intensely blackened scars</strong></li>
<li><strong>Larger than 2 cm, up to 10 cm</strong></li>
<li><strong>Consist of dense collagen and pigment</strong></li>
</ul></li>
</ul>
<p><strong>Progressive massive fibrosis in a coal worker</strong></p>
<p><strong>Large amount of black pigment is associated with fibrosis</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases19.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Progressive massive fibrosis superimposed on coal workers’ pneumoconiosis</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases20.png"></p>
<ul>
<li><strong>10% of cases of simple CWP progress to PMF</strong></li>
<li><strong>If smoking-related risk has been taken into account</strong>
<ul>
<li><strong>No increased frequency of lung carcinoma in coal miners</strong>
<ul>
<li><strong>Different from silica and asbestos exposures</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="silicosis" class="title-slide slide level1 center">
<h1>Silicosis</h1>
<ul>
<li><strong>Most prevalent chronic occupational disease in the world</strong></li>
<li><strong>Inhalation of crystalline silica, in occupational settings</strong></li>
<li><strong>Silica</strong>
<ul>
<li><strong>Crystalline</strong>
<ul>
<li><strong>Quartz, cristobalite, and tridymite</strong>
<ul>
<li><strong>When mixed with other minerals, quartz has a reduced fibrogenic effect</strong>
<ul>
<li><strong>Iron-containing hematite provides a protective effect</strong></li>
</ul></li>
</ul></li>
<li><strong>Most toxic and fibrogenic</strong></li>
</ul></li>
<li><strong>Amorphous forms</strong></li>
</ul></li>
<li><strong>Particles interact with epithelial cells and macrophages</strong></li>
<li><strong>Pulmonary macrophages</strong>
<ul>
<li><strong>IL-1</strong></li>
<li><strong>TNF</strong></li>
<li><strong>Fibronectin</strong></li>
<li><strong>Lipid mediators</strong></li>
<li><strong>Oxygen-derived free radicals</strong></li>
<li><strong>Fibrogenic cytokines</strong></li>
</ul></li>
<li><strong>Anti-TNF monoclonal antibodies can block lung fibrosis in mice</strong></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases21.png"></p>
<p><strong>Silicotic nodules</strong></p>
<p><strong>Early stages</strong></p>
<p><strong>Tiny, barely palpable, discrete, pale-to-blackened nodules</strong></p>
<p><strong>Upper zones of the lungs</strong></p>
<p><strong>Advanced silicosis</strong></p>
<p><strong>Scarring contracted the upper lobe into a small dark mass</strong></p>
<p><strong>Dense pleural thickening</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>Concentrically arranged hyalinized collagen fibers</strong></p>
<p><strong>Surrounding an amorphous center</strong></p>
<p><strong>Whorled appearance of the collagen fibers is distinctive for silicosis</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases22.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Polarized microscopy</strong>
<ul>
<li><strong>Weakly birefringent silica particles in the center of the nodules</strong></li>
</ul></li>
<li><strong>Disease progresses</strong></li>
<li><strong>Individual nodules may coalesce into hard, collagenous scars</strong></li>
<li><strong>Progression to progressive massive fibrosis</strong></li>
<li><strong>Lung parenchyma may be compressed or overexpanded</strong></li>
<li><strong>Honeycomb pattern may develop</strong></li>
<li><strong>Fibrotic lesions occur in the hilar lymph nodes and pleura</strong></li>
<li><strong>Thin sheets of calcification occur in the lymph nodes</strong>
<ul>
<li><strong>Radiographically as “eggshell” calcification</strong></li>
<li><strong>Calcium surrounding a zone lacking calcification</strong></li>
</ul></li>
<li><strong>End stage lung and heart diseases</strong></li>
<li><strong>Silicosis is associated with an increased susceptibility to tuberculosis</strong>
<ul>
<li><strong>Depression of cell-mediated immunity</strong></li>
<li><strong>Crystalline silica may inhibit the ability of pulmonary macrophages to kill phagocytosed mycobacteria</strong></li>
</ul></li>
<li><strong>Crystalline silica from occupational sources is carcinogenic in humans</strong>
<ul>
<li><strong>The relationship between silica exposure and subsequent lung cancer is controversial</strong></li>
</ul></li>
</ul>
</section>

<section id="asbestosis-and-asbestos-related-diseases" class="title-slide slide level1 center">
<h1>Asbestosis andAsbestos-Related Diseases</h1>
<p><strong>Occupational exposure to asbestos</strong></p>
<p><strong>Parenchymal interstitial fibrosis (asbestosis )</strong></p>
<p><strong>Localized fibrous plaques or, rarely, diffuse fibrosis in the pleura</strong></p>
<p><strong>Pleural effusions</strong></p>
<p><strong>Lung carcinomas</strong></p>
<p><strong>Malignant pleural and peritoneal mesotheliomas</strong></p>
<p><strong>Laryngeal carcinoma</strong></p>
<p><strong>an asbestos body, revealing the typical beading and knobbed ends </strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases23.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><strong>an asbestos body, revealing the typical beading and knobbed ends </strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases24.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="asbestos" class="title-slide slide level1 center">
<h1>Asbestos</h1>
<p><strong>Concentration, size, shape, and solubility of the different forms of asbestos affect pathogenesis</strong></p>
<p><strong>Two distinct forms of asbestos</strong></p>
<p><strong>Serpentine</strong></p>
<p><strong>Amphibole</strong></p>
<p><strong>Both are pathogenic for all diseases</strong></p>
</section>

<section id="serpentine" class="title-slide slide level1 center">
<h1>Serpentine</h1>
<p><strong>Fiber is curly and flexible</strong></p>
<p><strong>Serpentine chrysotile accounts for most of the asbestos used in industry</strong></p>
<p><strong>Impacted in the upper respiratory passages and removed by the mucociliary elevator</strong></p>
<p><strong>Those that are trapped in the lungs are gradually leached from the tissues, because they are more soluble than amphiboles </strong></p>
</section>

<section id="amphibole" class="title-slide slide level1 center">
<h1>Amphibole</h1>
<p><strong>Fiber is straight, stiff, and brittle</strong></p>
<p><strong>More pathogenic than the serpentine chrysotile</strong></p>
<p><strong>Align themselves in the airstream → delivered deeper into the lungs → penetrate epithelial cells to reach the interstitium</strong></p>
</section>

<section id="both-forms-cause-disease" class="title-slide slide level1 center">
<h1>Both forms cause disease</h1>
<ul>
<li><strong>Increasing exposure to either form</strong>
<ul>
<li><strong>associated with a higher incidence of all asbestos-related diseases</strong></li>
</ul></li>
<li><strong>Interaction of particulates with lung macrophages → fibrosis</strong></li>
<li><strong>Functions as both a tumor initiator and a promoter</strong>
<ul>
<li><strong>Reactive free radicals generated by asbestos fibers → mesothelial tumors</strong></li>
<li><strong>Potentially toxic chemicals adsorbed onto the asbestos fibers</strong>
<ul>
<li><strong>Tobacco smoking</strong></li>
</ul></li>
</ul></li>
</ul>
</section>

<section id="asbestosis" class="title-slide slide level1 center">
<h1>Asbestosis</h1>
<p><strong>Diffuse pulmonary interstitial fibrosis</strong></p>
<p><strong>Indistinguishable from UIP</strong></p>
<p><strong>Except for the presence of asbestos bodies</strong></p>
</section>

<section id="asbestos-bodies" class="title-slide slide level1 center">
<h1>Asbestos Bodies</h1>
<ul>
<li><strong>Golden brown, fusiform or beaded rods with a translucent center</strong></li>
<li><strong>Coated with an iron-containing proteinaceous material</strong></li>
<li><strong>Formed when macrophages attempt to phagocytose asbestos fibers</strong>
<ul>
<li><strong>The iron is derived from phagocyte ferritin</strong></li>
</ul></li>
<li><strong>Can be found in the lungs of normal persons</strong>
<ul>
<li><strong>Much lower concentrations and without an accompanying interstitial fibrosis.</strong></li>
</ul></li>
</ul>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases25.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
</section>

<section id="asbestosis-1" class="title-slide slide level1 center">
<h1>Asbestosis</h1>
<ul>
<li><strong>Begins in the lower lobes and subpleurally</strong>
<ul>
<li><strong>In contrast with CWP and silicosis</strong></li>
</ul></li>
<li><strong>Middle and upper lobes of the lungs become affected as fibrosis progresses</strong></li>
<li><strong>Contraction of the fibrous tissue</strong>
<ul>
<li><strong>Distorts the normal architecture</strong></li>
<li><strong>Creating enlarged air spaces enclosed within thick fibrous walls</strong></li>
<li><strong>Affected regions become honeycombed</strong></li>
</ul></li>
<li><strong>Fibrosis develops in the visceral pleura</strong>
<ul>
<li><strong>Adhesions between the lungs and the chest wall</strong></li>
</ul></li>
<li><strong>Scarring trap and narrow pulmonary arteries and arterioles</strong>
<ul>
<li><strong>Pulmonary hypertension and cor pulmonale</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases26.png"></p>
<p><strong>Asbestosis</strong></p>
<p><strong>Markedly thickened visceral pleura covers the lateral and diaphragmatic surface</strong></p>
<p><strong>Severe interstitial fibrosis diffusely affecting the lower lobe</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases27.png"></p>
</section>

<section id="pleural-plaques" class="title-slide slide level1 center">
<h1>Pleural plaques</h1>
<p><strong>Most common manifestation of asbestos exposure</strong></p>
<p><strong>Well-circumscribed plaques of dense collagen</strong></p>
<p><strong>Often contain calcium</strong></p>
<p><strong>Most frequently on the anterior and posterolateral aspects of the parietal pleura and over the domes of the diaphragm</strong></p>
<p><strong>Do not contain asbestos bodies</strong></p>
<p><strong>Rarely occur in persons with no history or evidence of asbestos exposure </strong></p>
<p><strong>Uncommonly, asbestos exposure induces pleural effusion or diffuse pleural fibrosis.</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases28.png" class="r-stretch"></section>

<section id="asbestosis-2" class="title-slide slide level1 center">
<h1>Asbestosis</h1>
<p><strong>End stage lung and heart diseases</strong></p>
<p><strong>The risk of lung carcinoma is increased 5x</strong></p>
<p><strong>Mesothelioma risk 1000x</strong></p>
<p><strong>Concomitant cigarette smoking greatly increases the risk of lung carcinoma but not that of mesothelioma</strong></p>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases29.png" class="r-stretch"></section>

<section id="drug--and-radiation-induced-pulmonary-diseases" class="title-slide slide level1 center">
<h1>DRUG- AND RADIATION-INDUCED PULMONARY DISEASES</h1>

</section>

<section id="bleomycin" class="title-slide slide level1 center">
<h1>Bleomycin</h1>
<p><strong>Anticancer agent</strong></p>
<p><strong>Pneumonitis and interstitial fibrosis</strong></p>
<p><strong>Direct toxicity of the drug</strong></p>
<p><strong>Stimulating the influx of inflammatory cells into the alveoli</strong></p>
</section>

<section id="amiodarone" class="title-slide slide level1 center">
<h1>Amiodarone</h1>
<p><strong>An antiarrhythmic agent</strong></p>
<p><strong>Associated with risk for pneumonitis and fibrosis</strong></p>
</section>

<section id="radiation-pneumonitis" class="title-slide slide level1 center">
<h1>Radiation pneumonitis</h1>
<ul>
<li><strong>Complication of therapeutic irradiation of pulmonary and other thoracic tumors</strong></li>
<li><strong>Acute radiation pneumonitis</strong>
<ul>
<li><strong>1-6 months after therapy</strong></li>
<li><strong>in as many as 20% of the patients</strong></li>
<li><strong>Fever, dyspnea out of proportion to the volume of irradiated lung, pleural effusion, and development of pulmonary infiltrates corresponding to the area of radiation</strong></li>
<li><strong>May resolve with corticosteroid therapy or progress</strong></li>
</ul></li>
<li><strong>Chronic radiation pneumonitis</strong>
<ul>
<li><strong>Progress from acute form</strong></li>
<li><strong>Associated with pulmonary fibrosis</strong></li>
</ul></li>
</ul>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases30.png" class="r-stretch"></section>

<section id="granulomatous-diseases" class="title-slide slide level1 center">
<h1>GRANULOMATOUS DISEASES</h1>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases31.png" class="r-stretch"></section>

<section id="sarcoidosis" class="title-slide slide level1 center">
<h1>SARCOIDOSIS</h1>

</section>

<section id="sarcoidosis-1" class="title-slide slide level1 center">
<h1>Sarcoidosis</h1>
<ul>
<li><p><strong>A multisystem disease</strong></p></li>
<li><p><strong>Unknown etiology</strong></p></li>
<li><p><strong>Characterized by noncaseating granulomas in many tissues and organs</strong></p></li>
<li><p><strong>Other diseases sometimes also produce noncaseating granulomas</strong></p>
<ul>
<li><strong>mycobacterial or fungal infections and berylliosis</strong></li>
</ul></li>
<li><p><strong>Diagnosis of sarcoidosis is one of exclusion</strong></p></li>
<li><p><strong>Bilateral hilar lymphadenopathy</strong></p></li>
<li><p><strong>Lung involvement</strong></p>
<ul>
<li><strong>Visible on chest radiographs</strong></li>
</ul></li>
<li><p><strong>Eye and skin involvement, 25% of cases</strong></p></li>
<li><p><strong>Adults &lt;40 year</strong></p></li>
<li><p><strong>Danish and Swedish populations, African Americans (10x whites)</strong></p></li>
<li><p><strong>Higher prevalence among nonsmokers</strong></p></li>
<li><p><strong>Development of a cell-mediated response to an unidentified antigen</strong></p></li>
<li><p><strong>Intra-alveolar and interstitial accumulation of CD4+ T</strong> <strong>H</strong> <strong>1 cells</strong></p></li>
<li><p><strong>Oligoclonal expansion of T cell subsets</strong></p></li>
<li><p><strong>Increases in T cell–derived T</strong> <strong>H</strong> <strong>1 cytokines</strong></p>
<ul>
<li><strong>IL-2 and IFN-γ</strong></li>
</ul></li>
<li><p><strong>T cell expansion and macrophage activation</strong></p></li>
<li><p><strong>Increases in several cytokines in the local environment</strong></p>
<ul>
<li><strong>IL-8, TNF, macrophage inflammatory protein-1α</strong></li>
</ul></li>
<li><p><strong>Recruitment of additional T cells and monocytes</strong></p></li>
<li><p><strong>Formation of granulomas</strong></p></li>
<li><p><strong>Anergy to common skin test antigens</strong></p>
<ul>
<li><strong>Candida or purified protein derivative (PPD)</strong></li>
<li><strong>Result from pulmonary recruitment of CD4+ T cells</strong></li>
<li><strong>Peripheral depletion</strong></li>
</ul></li>
<li><p><strong>Polyclonal hypergammaglobulinemia</strong></p></li>
<li><p><strong>Association with HLA-A1 and HLA-B8</strong></p></li>
<li><p><strong>After lung transplantation, sarcoidosis recurs in the new lungs in 75%</strong></p></li>
<li><p><strong>Putative antigens have been proposed</strong></p>
<ul>
<li><strong>Viruses, mycobacteria, Borrelia, pollen</strong></li>
<li><strong>No proof</strong></li>
</ul></li>
</ul>
</section>

<section id="histopathologic-feature-of-sarcoidosis" class="title-slide slide level1 center">
<h1>Histopathologic feature of sarcoidosis</h1>
<ul>
<li><strong>Noncaseating epithelioid granuloma, irrespective of the organ involved</strong></li>
<li><strong>Discrete, compact collection of epithelioid cells</strong></li>
<li><strong>Rimmed by an outer zone of largely CD4+ T cells</strong></li>
<li><strong>Epithelioid cells are derived from macrophages and are characterized by abundant eosinophilic cytoplasm and vesicular nuclei</strong></li>
<li><strong>Intermixed multinucleate giant cells formed by fusion of macrophages</strong></li>
<li><strong>A thin layer of laminated fibroblasts is present peripheral to the granuloma</strong></li>
<li><strong>Over time</strong>
<ul>
<li><strong>Entire granuloma with a hyalinized scar</strong></li>
</ul></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases32.png"></p>
<p><strong>Sarcoid</strong></p>
<p><strong>Characteristic peribronchial noncaseating granulomas with many giant cells</strong></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Schaumann bodies</strong>
<ul>
<li><strong>Laminated concretions composed of calcium and proteins</strong></li>
</ul></li>
<li><strong>Asteroid bodies</strong>
<ul>
<li><strong>Stellate inclusions enclosed within giant cells</strong></li>
</ul></li>
<li><strong>They are not specific</strong></li>
</ul>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases33.jpg"></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases34.jpg"></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases35.jpg"></p>
</section>

<section id="sarcoidosis-2" class="title-slide slide level1 center">
<h1>Sarcoidosis</h1>
<ul>
<li><strong>Skin</strong>
<ul>
<li><strong>Erythema nodosum</strong></li>
</ul></li>
<li><strong>Eye</strong>
<ul>
<li><strong>Iritis or iridocyclitis</strong></li>
<li><strong>Corneal opacities, glaucoma, total loss of vision</strong></li>
<li><strong>Choroiditis, retinitis, and optic nerve involvement</strong></li>
</ul></li>
<li><strong>Lacrimal glands</strong>
<ul>
<li><strong>Sicca syndrome</strong></li>
</ul></li>
<li><strong>Parotitis</strong>
<ul>
<li><strong>Mikulicz syndrome</strong></li>
</ul></li>
<li><strong>Liver</strong></li>
<li><strong>Spleen</strong></li>
<li><strong>Bone marrow </strong></li>
<li><strong>Hypercalcemia and hypercalciuria</strong>
<ul>
<li><strong>production of active vitamin D by the mononuclear phagocytes in the granulomas</strong></li>
</ul></li>
</ul>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases36.png" class="r-stretch"></section>

<section id="hypersensitivity-pneumonitis" class="title-slide slide level1 center">
<h1>HYPERSENSITIVITY PNEUMONITIS</h1>

</section>

<section id="hypersensitivity-pneumonitis-1" class="title-slide slide level1 center">
<h1>Hypersensitivity Pneumonitis</h1>
<p><strong>Allergic alveolitis</strong></p>
<p><strong>Occupational disease</strong></p>
<p><strong>Heightened sensitivity to inhaled antigens such as in moldy hay</strong></p>
<p><strong>The damage at the level of alveoli</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases37.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Bronchoalveolar lavage specimens</strong>
<ul>
<li><strong>increased numbers of T lymphocytes of both CD4+ and CD8+ phenotype.</strong></li>
</ul></li>
<li><strong>Type III hypersensitivity</strong>
<ul>
<li><strong>Specific precipitating antibodies in serum,</strong></li>
<li><strong>Complement and immunoglobulins within vessel walls by immunofluorescence</strong></li>
</ul></li>
<li><strong>Type IV hypersensitivity</strong>
<ul>
<li><strong>Presence of noncaseating granulomas in 2/3 of patients</strong></li>
</ul></li>
<li><strong>Patchy mononuclear cell infiltrates in the pulmonary interstitium</strong></li>
<li><strong>Characteristic peribronchiolar accentuation</strong></li>
<li><strong>Lymphocytes predominate</strong></li>
<li><strong>Plasma cells and epithelioid cells also are present</strong></li>
<li><strong>Acute forms of the disease, neutrophils may be seen</strong></li>
<li><strong>Interstitial noncaseating granulomas</strong>
<ul>
<li><strong>peribronchiolar location</strong></li>
</ul></li>
<li><strong>Advanced chronic cases</strong>
<ul>
<li><strong>Diffuse interstitial fibrosis occurs.</strong></li>
</ul></li>
</ul>
<p><strong>Hypersensitivity pneumonitis</strong></p>
<p><strong>Loosely formed interstitial granulomas and chronic inflammation are characteristic</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases38.png"></p>
<p><strong>Robbins Basic Pathology</strong></p>
<p><img data-src="img%5CChronic-Interstitial-Lung-Diseases39.png"></p>
</section>

<section id="pulmonary-eosinophilia" class="title-slide slide level1 center">
<h1>PULMONARY EOSINOPHILIA</h1>

</section>

<section id="pulmonary-eosinphilia" class="title-slide slide level1 center">
<h1>Pulmonary Eosinphilia</h1>
<p><strong>Infiltration and activation of eosinophils</strong></p>
<p><strong>Elevated levels of alveolar IL-5</strong></p>
<p><strong>Diverse diseases of immunologic origin</strong></p>
</section>

<section id="acute-eosinophilic-pneumonia-with-respiratory-failure" class="title-slide slide level1 center">
<h1>Acute eosinophilic pneumonia with respiratory failure</h1>
<p><strong>Rapid onset of fever, dyspnea, hypoxia</strong></p>
<p><strong>Diffuse pulmonary infiltrates on chest radiographs</strong></p>
<p><strong>Bronchoalveolar lavage fluid typically contains more than 25% eosinophils Prompt response to corticosteroids</strong></p>
</section>

<section id="simple-pulmonary-eosinophilia" class="title-slide slide level1 center">
<h1>Simple pulmonary eosinophilia</h1>
<p><strong>Loeffler syndrome</strong></p>
<p><strong>Transient pulmonary lesions</strong></p>
<p><strong>Eosinophilia in the blood</strong></p>
<p><strong>Alveolar septa are thickened by an infiltrate containing eosinophils and occasional giant cells</strong></p>
<ul>
<li><strong>Tropical eosinophilia</strong>
<ul>
<li><strong>Infection with microfilariae and helminthic parasites</strong></li>
</ul></li>
<li><strong>Secondary eosinophilia</strong>
<ul>
<li><strong>Association with asthma</strong></li>
<li><strong>Drug allergies</strong></li>
<li><strong>Vasculitis</strong></li>
</ul></li>
</ul>
</section>

<section id="idiopathic-chronic-eosinophilic-pneumonia" class="title-slide slide level1 center">
<h1>Idiopathic chronic eosinophilic pneumonia</h1>
<p><strong>Aggregates of lymphocytes and eosinophils within the septal walls and the alveolar spaces</strong></p>
<p><strong>Periphery of the lung fields</strong></p>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases40.png" class="r-stretch"></section>

<section id="smoking-related-interstitial-diseases" class="title-slide slide level1 center">
<h1>SMOKING-RELATED INTERSTITIAL DISEASES</h1>

</section>

<section id="smoking-related-interstitial-diseases-1" class="title-slide slide level1 center">
<h1>Smoking-Related Interstitial Diseases</h1>
<ul>
<li><strong>Obstructive pulmonary disease</strong>
<ul>
<li><strong>Emphysema</strong></li>
<li><strong>Chronic bronchitis</strong></li>
</ul></li>
<li><strong>Restrictive or interstitial lung diseases</strong>
<ul>
<li><strong>Desquamative interstitial pneumonia (DIP)</strong></li>
<li><strong>Respiratory bronchiolitis</strong></li>
</ul></li>
</ul>
</section>

<section id="desquamative-interstitial-pneumonia" class="title-slide slide level1 center">
<h1>Desquamative interstitial pneumonia</h1>
<p><strong>Accumulation of large numbers of macrophages</strong></p>
<p><strong>Abundant cytoplasm containing dusty-brown pigment</strong></p>
<p><strong>Smoker’s macrophages</strong></p>
<p><strong>Desquamative interstitial pneumonia</strong></p>
<p><strong>Accumulation of large numbers of macrophages within the alveolar spaces, </strong></p>
<p><strong>Slight fibrous thickening of the alveolar walls</strong></p>

<img data-src="img%5CChronic-Interstitial-Lung-Diseases41.png" class="r-stretch"><p><strong>Robbins Basic Pathology</strong></p>
<ul>
<li><strong>Alveolar septa are thickened</strong>
<ul>
<li><strong>Sparse inflammatory infiltrate</strong>
<ul>
<li><strong>Lymphocytes</strong></li>
</ul></li>
<li><strong>Interstitial fibrosis</strong>
<ul>
<li><strong>Mild</strong></li>
</ul></li>
</ul></li>
<li><strong>Good prognosis with excellent response to steroid therapy and smoking cessation</strong></li>
</ul>
</section>

<section id="respiratory-bronchiolitis" class="title-slide slide level1 center">
<h1>Respiratory bronchiolitis</h1>
<p><strong>Pigmented intraluminal macrophages similar to DIP</strong></p>
<p><strong>Bronchiolocentric distribution</strong></p>
<p><strong>Mild peribronchiolar fibrosis</strong></p>
<div class="footer footer-default">

</div>
</section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="chronic-interstitial-lung-diseases_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: false,

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>